V
Verve Therapeutics (VERV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Verve Therapeutics (VERV)
Verve Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops therapies that safely edit adult human genome to permanently reduce a person's risk of coronary artery disease. Verve Therapeutics serves customers world... Read more
- USD11.22
- USD11.32
- USD11.22
- USD11.41
- 163.40%
- 60M
- 4.14M
- 6.35M
- 986M
- 2.86
- 137.40%
Stock News
4 hours ago
Tesla Stock Investors Just Got Bad News From Wall Street, but There's a Silver Lining
Yahoo
8 hours ago
Merck: Don't Let Today's Bargain Opportunity Pass You By
SeekingAlpha
8 hours ago
UnitedHealth: Pivotal Changes Underway
SeekingAlpha
8 hours ago
Trump's 'big, beautiful bill' clears key Senate hurdle after high drama
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
